Skip to content

Organ Dysfunction Associated With Intra Abdominal Pressures in Liver Transplantation

Organ Dysfunction Associated With Intraabdominal Pressures in Liver Transplantation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04463745
Acronym
OIL
Enrollment
25
Registered
2020-07-09
Start date
2020-07-15
Completion date
2021-06-30
Last updated
2021-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cirrhosis, Liver, Intra-Abdominal Hypertension, Liver Diseases, Organ Dysfunction Syndrome

Keywords

organ dysfunction, intra-abdominal pressure, liver transplantation, liver cirrhosis

Brief summary

Patients with end stage liver disease have varying degrees of intra-abdominal hypertension (IAH) due to the presence of ascites. The perioperative events may either relieve or aggravate the intra-abdominal pressures. Intra-abdominal hypertension has damaging effect on various organ systems. There is an increase in intracranial pressures and a decrease in cerebral perfusion pressures associated with IAH . In the heart, there is an increase of right atrial pressures, increase in systemic vascular resistance and decrease in cardiac output . Pulmonary complications include increase in the peak, mean and plateau airway pressures, with decreased compliance . Renal dysfunction is an early effect of raised intra-abdominal pressure, resulting from decreased renal blood flow, shunting of blood to the medulla, mechanical compression of the kidneys and increased pressures in the renal veins . We would study the intra-abdominal pressures in liver transplant recipients and record hemodynamic, respiratory, cardiac and renal function prospectively. Follow up data for 6 days for neurological, respiratory, cardiac and renal complications will be collected, along with hospital stay, ICU stay and mortality. The association between intra-abdominal pressures and these outcomes will be analysed.

Interventions

None listed

Sponsors

Institute of Liver and Biliary Sciences, India
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* patients undergoing liver transplantation * 18 to 65 years

Exclusion criteria

* pregnant patients * primary diagnosis of Acute liver failure and acute on chronic liver failure

Design outcomes

Primary

MeasureTime frameDescription
28 day mortality28 daysmortality of any cause in the fist 28 days after transplantation
duration of icu stay28 daystime period spent in the intensive care unit

Secondary

MeasureTime frameDescription
Acute kidney injury in 1st week7 daysincidence of acute kidney injury in 1 week of transplantation
Respiratory complications7 daysincludes duration of ventilation, incidence of vap
major neurological complications7 daysany major neurological event

Countries

India

Contacts

Primary ContactKarthik Ponnappan
kdtkp@yahoo.com+919840163951

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026